Shinya Ashizuka

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Current status and challenges of endoscopic balloon dilation for small bowel stricture in Crohn's disease

Current status and challenges of endoscopic balloon dilation for small bowel stricture in Crohn's disease

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: March 11, 2026

Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team.

Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team.

Journal: Journal of gastroenterology

Published: January 23, 2026

Effectiveness, safety, and pharmacokinetics of the infliximab biosimilar CT-P13 after non-medical switch from the infliximab originator in patients with inflammatory bowel disease.

Effectiveness, safety, and pharmacokinetics of the infliximab biosimilar CT-P13 after non-medical switch from the infliximab originator in patients with inflammatory bowel disease.

Journal: Intestinal research

Published: June 30, 2025

Effect of a self-assembling peptide hydrogel on delayed bleeding following endoscopic sphincterotomy: Prospective pilot cohort study.

Effect of a self-assembling peptide hydrogel on delayed bleeding following endoscopic sphincterotomy: Prospective pilot cohort study.

Journal: Endoscopy international open

Published: May 20, 2025

Induction Efficacy and Safety of Upadacitinib for Active Crohn's Disease in Japanese Patients: A Multicenter Retrospective Study.

Induction Efficacy and Safety of Upadacitinib for Active Crohn's Disease in Japanese Patients: A Multicenter Retrospective Study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: May 10, 2025

Expert consensus on diagnostic guidelines for pediatric inflammatory bowel disease in Japan.

Expert consensus on diagnostic guidelines for pediatric inflammatory bowel disease in Japan.

Journal: Journal of gastroenterology

Published: April 22, 2025

Fecal Calprotectin is a Useful Biomarker for Defining Small Bowel Endoscopic Remission in Crohn's Disease Without Active Colonic Lesions: A Prospective Multicenter Study from the IBD-Quality Team.

Fecal Calprotectin is a Useful Biomarker for Defining Small Bowel Endoscopic Remission in Crohn's Disease Without Active Colonic Lesions: A Prospective Multicenter Study from the IBD-Quality Team.

Journal: Inflammatory bowel diseases

Published: December 17, 2024

Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn's disease activity in the small bowel.

Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn's disease activity in the small bowel.

Journal: Journal of gastroenterology

Published: November 16, 2024

Frontiers and challenges in diagnosis and treatment for Crohn's disease -from epidemiology to treatment

Frontiers and challenges in diagnosis and treatment for Crohn's disease -from epidemiology to treatment

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: July 10, 2024

Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study.

Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study.

Journal: Intestinal research

Published: March 23, 2023

A novel self-assembling peptide hemostatic gel as an option for initial hemostasis in endoscopic sphincterotomy-related hemorrhage: a case series.

A novel self-assembling peptide hemostatic gel as an option for initial hemostasis in endoscopic sphincterotomy-related hemorrhage: a case series.

Journal: Clinical journal of gastroenterology

Published: June 20, 2022

Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial.

Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial.

Journal: Journal of gastroenterology and hepatology

Published: October 28, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026